---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-068314"
form_type: "8-K"
ticker: "NWBO"
cik: "0001072379"
company_name: "NORTHWEST BIOTHERAPEUTICS INC"
filed_at: "2024-06-04T23:59:59+00:00"
generated_at: "2026-06-01T06:27:04.581967+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Northwest Biotherapeutics sells 8.125M shares at $0.40 to SIO Capital for $3.25M

## Summary
- SPA signed June 4, 2024; closing expected June 5, 2024.
- Gross proceeds of $3,250,000 from sale of 8,125,000 shares of common stock.
- Proceeds to be used for ongoing business operations.
- SIO Capital Management LLC is the purchaser; Joseph Gunnar & Co. acted as placement agent.

## SEC filing metadata
- accession: 0001104659-24-068314
- form_type: 8-K
- ticker: NWBO
- cik: 0001072379
- company_name: NORTHWEST BIOTHERAPEUTICS INC
- filed_at: 2024-06-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1072379/000110465924068314/0001104659-24-068314-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1072379/000110465924068314/tm2416435d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-068314
- JSON: https://secwatch.observer/filing/0001104659-24-068314.json
- Plain text: https://secwatch.observer/filing/0001104659-24-068314.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.